» Articles » PMID: 35910696

Characteristics and Management of Children With Suspected COVID-19 Admitted to Hospitals in India: Implications for Future Care

Abstract

Introduction: There is a growing focus on researching the management of children with COVID-19 admitted to hospital, especially among developing countries with new variants alongside concerns with the overuse of antibiotics. Patient care can be improved with guidelines, but concerns with the continued imprudent prescribing of antimicrobials, including antibiotics, antivirals, and antimalarials.

Objective: Consequently, a need to document the current management of children with COVID-19 across India. Key outcome measures included the percentage of prescribed antimicrobials, adherence to current guidelines, and mortality.

Methodology: A point prevalence study using specially developed report forms among 30 hospitals in India.

Results: The majority of admitted children were aged between 11 and 18 years (70%) and boys (65.8%). Reasons for admission included respiratory distress, breathing difficulties, and prolonged fever. 75.3% were prescribed antibiotics typically empirically (68.3% overall), with most on the Watch list (76.7%). There were no differences in antibiotic prescribing whether hospitals followed guidelines or not. There was also appreciable prescribing of antimalarials (21.4% of children), antivirals (15.2%), and antiparasitic medicines (27.2%) despite limited evidence. The majority of children (92.2%) made a full recovery.

Conclusion: It was encouraging to see low hospitalization rates. However, concerns about high empiric use of antibiotics and high use of antimalarials, antivirals, and antiparasitic medicines exist. These can be addressed by instigating appropriate stewardship programs.

Citing Articles

Impact of COVID-19 on Antimicrobial Stewardship Activities in Hospitalised Children: A Scoping Review.

Mohammed Z, Grant G, Irwin A, Hattingh L, Eshwara V, Okonkwo R J Paediatr Child Health. 2025; 61(3):333-343.

PMID: 39844000 PMC: 11883052. DOI: 10.1111/jpc.16786.


Point Prevalence Survey of Antimicrobial Use and Resistance during the COVID-19 Era among Hospitals in Saudi Arabia and the Implications.

Haseeb A, Almarzoky Abuhussain S, Alghamdi S, Bahshwan S, Mahrous A, Alzahrani Y Antibiotics (Basel). 2023; 12(11).

PMID: 37998811 PMC: 10668720. DOI: 10.3390/antibiotics12111609.


The Impact of COVID-19 on Knowledge, Beliefs, and Practices of Ni-Vanuatu Health Workers Regarding Antibiotic Prescribing and Antibiotic Resistance, 2018 and 2022: A Mixed Methods Study.

Foxlee N, Taleo S, Mathias A, Townell N, McIver L, Lau C Trop Med Infect Dis. 2023; 8(10).

PMID: 37888605 PMC: 10611053. DOI: 10.3390/tropicalmed8100477.


COVID-19 vaccine uptake and associated factors among adolescents and youths: Findings and implications for future vaccination programmes.

Mudenda S, Meyer J, Fadare J, Ogunleye O, Saleem Z, Matafwali S PLOS Glob Public Health. 2023; 3(9):e0002385.

PMID: 37729153 PMC: 10511127. DOI: 10.1371/journal.pgph.0002385.


Awareness and Practices towards Vaccinating Their Children against COVID-19: A Cross-Sectional Study among Pakistani Parents.

Harmain Z, Alkubaisi N, Hasnain M, Salman M, Baraka M, Ul Mustafa Z Healthcare (Basel). 2023; 11(17).

PMID: 37685412 PMC: 10487428. DOI: 10.3390/healthcare11172378.


References
1.
Haque M, Kumar S, Charan J, Bhatt R, Islam S, Dutta S . Utilisation, Availability and Price Changes of Medicines and Protection Equipment for COVID-19 Among Selected Regions in India: Findings and Implications. Front Pharmacol. 2021; 11:582154. PMC: 7898674. DOI: 10.3389/fphar.2020.582154. View

2.
Godman B, Egwuenu A, Haque M, Malande O, Schellack N, Kumar S . Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries. Life (Basel). 2021; 11(6). PMC: 8229985. DOI: 10.3390/life11060528. View

3.
Skosana P, Schellack N, Godman B, Kurdi A, Bennie M, Kruger D . A point prevalence survey of antimicrobial utilisation patterns and quality indices amongst hospitals in South Africa; findings and implications. Expert Rev Anti Infect Ther. 2021; 19(10):1353-1366. DOI: 10.1080/14787210.2021.1898946. View

4.
Langford B, So M, Raybardhan S, Leung V, Soucy J, Westwood D . Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect. 2021; 27(4):520-531. PMC: 7785281. DOI: 10.1016/j.cmi.2020.12.018. View

5.
Malek A, Khadga M, Zahid M, Mojib S, Debnath R, Khan S . Multisystem Inflammatory Syndrome of a Neonate From a COVID-19-Infected Mother: A Case Report. Cureus. 2022; 14(3):e23046. PMC: 8994695. DOI: 10.7759/cureus.23046. View